ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMLX Amylyx Pharmaceuticals Inc

1.88
-0.05 (-2.59%)
09 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00345k21.89M71.43M98.22M102.69M108.45M
Operating Income -47.81M-54.25M-54.68M-44.59M-2.05M20.2M18.72M1.93M
Pre Tax Income -47.7M-53.89M-53.88M-42.13M1.4M24.01M22.41M6.48M
Net Income -47.85M-54.07M-53.76M-42.7M1.57M22.07M20.89M4.73M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -47.83M-54.3M-54.54M-44.59M-2.32M20.2M17.89M1.93M
EBITDA -47.78M-54.15M-54.52M-44.41M-1.85M20.48M19.02M2.24M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.43M1.43M285k22.23M380.79M
Operating Income -13.55M-13.55M-82.69M-201.34M38.8M
Pre Tax Income -13.72M-13.72M-87.93M-197.6M54.3M
Net Income -13.72M-13.72M-87.93M-198.38M49.27M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -2.288-2.288-3.162-2.2720.558
EBIT -13.56M-13.56M-82.74M-201.34M38.8M
EBITDA -13.55M-13.55M-82.64M-200.85M39.89M

Your Recent History

Delayed Upgrade Clock